We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
biOasis Announces Completion of Acquisition of Intellectual Property
Product News

biOasis Announces Completion of Acquisition of Intellectual Property

biOasis Announces Completion of Acquisition of Intellectual Property
Product News

biOasis Announces Completion of Acquisition of Intellectual Property


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "biOasis Announces Completion of Acquisition of Intellectual Property"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

biOasis Technologies Inc. has announced that its wholly owned subsidiary biOasis Advanced Technologies Inc. ("BAT") has completed the acquisition of certain Intellectual Property pursuant to a Worldwide Assignment dated June 16, 2011 on terms as previously disclosed.

On August 5, 2011, the closing date, the Company paid $25,000 in cash and issued 350,000 warrants at an exercise price of $0.575 and 100,000 warrants at an exercise price of $0.50.

Each warrant is exercisable into one common share of the Company for a period of five years from the date of issuance. All of the warrants issued are subject to a hold period expiring December 6, 2011.

In the event that a patent with respect to the Intellectual Property is issued to BAT in either Europe or the United States of America, the Company will grant a further 300,000 warrants.

These further warrants shall be priced at the closing share price of the Company on the date of the issuance of such patent and in any case not less than $0.50 and shall be exercisable into one common share of the Company for a period of two years from date of grant.

Advertisement